Tuesday, 31 October 2023

Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs

The results come two weeks after Pfizer slashed its full-year adjusted earnings and revenue guidance and launched a sweeping $3.5 billion cost-cutting plan.

from Health and Science https://ift.tt/ZFpsEUu
https://ift.tt/7gFk8US
https://ift.tt/CTES870

Sunday, 29 October 2023

Some pharmacy staff from Walgreens, other chains are walking out again — here's what you need to know

The walkouts are the latest pushback against what pharmacy staff claim are harsh and unsafe working conditions that put both employees and patients at risk. 

from Health and Science https://ift.tt/fwLYMNc
https://ift.tt/iLFBHbg
https://ift.tt/COndKEN

Friday, 27 October 2023

We had a busy week of trades in an oversold market. Here's the day-by-day breakdown

This week, we purchased shares in companies that had promising earnings but negative stock reactions or demonstrated positive catalysts.

from Health and Science https://ift.tt/Ax6aEzI
https://ift.tt/GxR8yNJ
https://ift.tt/PAHRTOK

Pharmacy staff from Walgreens, CVS say they’re at a breaking point — here’s what their days look like

Workers are concerned that Walgreens and CVS are placing unreasonable demands on them, without providing enough resources to safely execute tasks. 

from Health and Science https://ift.tt/5hP3Egr
https://ift.tt/GxR8yNJ
https://ift.tt/PAHRTOK

Thursday, 26 October 2023

Pfizer's combination Covid, flu vaccine will move to final-stage trial after positive data

Pfizer, Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against Covid and the flu.

from Health and Science https://ift.tt/9sHKaih
https://ift.tt/jpxMIdZ
https://ift.tt/jOzIP1q

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition

Bristol Myers Squibb’s revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of blood cancer drug Revlimid.

from Health and Science https://ift.tt/BGRSpXb
https://ift.tt/kfIrZT4
https://ift.tt/qtLjmAk

Merck results beat expectations on strong Keytruda sales, surprise Covid drug growth

Merck's revenue and earnings beat expectations, and it hiked its sales forecast while lowering its profit outlook.

from Health and Science https://ift.tt/LUEYdm8
https://ift.tt/kfIrZT4
https://ift.tt/qtLjmAk

Wednesday, 25 October 2023

More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study

Eisai and Biogen said in a release that they plan to apply for U.S. approval of subcutaneous Leqembi by the end of March.

from Health and Science https://ift.tt/KcoeIzX
https://ift.tt/kfIrZT4
https://ift.tt/qtLjmAk

RSV vaccine from GSK shows potential to protect adults 50 to 59

The results suggest that GSK's shot could help protect a wider population from RSV, which causes thousands of hospitalizations and deaths each year.

from Health and Science https://ift.tt/tLqyQ96
https://ift.tt/kfIrZT4
https://ift.tt/qtLjmAk

Tuesday, 24 October 2023

Amazon considers offering veterinary telehealth as it looks to compete with Walmart

Amazon may join a growing list of retailers that offer pet telehealth as it looks to compete with Walmart and take a slice of the lucrative veterinary market.

from Health and Science https://ift.tt/byJlvK5
https://ift.tt/3NnMody
https://ift.tt/0ADvPen

As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data

Signos, a Silicon Valley startup that's trying to help consumers lose weight, raised $20 million in a funding round led by Cheyenne Ventures and GV.

from Health and Science https://ift.tt/Ypxr7FO
https://ift.tt/3NnMody
https://ift.tt/0ADvPen

Monday, 23 October 2023

Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers

Citi notched its estimate for incretin drug sales to $71 billion by 2035, up from its prior estimate of $55 billion. That view seems conservative. Here's why.

from Health and Science https://ift.tt/QyzGOlP
https://ift.tt/3NnMody
https://ift.tt/0ADvPen

Thursday, 19 October 2023

CVS to pull certain cold medicines containing decongestant phenylephrine from store shelves

CVS is voluntarily removing certain cough and cold medicines that contain phenylephrine as the only active ingredient from stores. 

from Health and Science https://ift.tt/w9zFPus
https://ift.tt/QCEcR7m
https://ift.tt/xpUYjbL

Sanofi to offer insulin product for $35 to all Americans through GoodRx

The effort comes after Sanofi, Eli Lilly and Novo Nordisk announced sweeping insulin price cuts earlier this year.

from Health and Science https://ift.tt/VrX58tC
https://ift.tt/QCEcR7m
https://ift.tt/xpUYjbL

Wednesday, 18 October 2023

Pfizer to price Covid drug Paxlovid at $1,390 per course

Paxlovid will transition to the private market in November, which comes as demand for Covid vaccines and treatments slumps nationwide.

from Health and Science https://ift.tt/ZCrnVf4
https://ift.tt/jmZupd1
https://ift.tt/Wv5rM7Q

Amazon begins delivering medications by drone in Texas

Amazon Pharmacy announced medications are available by drone delivery for certain customers in Texas

from Health and Science https://ift.tt/0V7yJpu
https://ift.tt/jmZupd1
https://ift.tt/Wv5rM7Q

Tuesday, 17 October 2023

Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge

It marks J&J's first quarterly results since the company completed the separation from its consumer health spinoff Kenvue in August.  

from Health and Science https://ift.tt/1uZM2jT
https://ift.tt/10QGyjA
https://ift.tt/7zXcfMs

Sunday, 15 October 2023

Rite Aid files for bankruptcy amid slowing sales, opioid litigation

Drugstore chain Rite Aid filed for bankruptcy as it faces a mounting debt pile, slowing sales and lawsuits alleging it oversupplied painkillers.

from Health and Science https://ift.tt/KrGilfz
https://ift.tt/XCKbjmu
https://ift.tt/AJtjRdm

When is it OK to violate your cost basis to buy more shares of a company?

Here's how to determine a good buying point when a stock doesn't look ready to come down anytime soon.

from Health and Science https://ift.tt/XLF5Yc6
https://ift.tt/XCKbjmu
https://ift.tt/AJtjRdm

Friday, 13 October 2023

Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump

Pfizer said it anticipates sales of its Covid treatment Paxlovid and its vaccine will be $9 billion less than it had expected.

from Health and Science https://ift.tt/vhqPQoJ
https://ift.tt/81UPu96
https://ift.tt/sUMzlT8

Pharmacy staff from Walgreens, other chains could stage nationwide walkout and rallies in coming weeks

The plans come after separate walkouts staged by pharmacy staff from CVS stores in the Kansas City area and Walgreens locations around the country.

from Health and Science https://ift.tt/qePXlFp
https://ift.tt/81UPu96
https://ift.tt/sUMzlT8

The U.S. has high maternal mortality rates — and it has gotten worse for Latinas

Nonprofits, health insurers and large employers such as Walmart are investing in support programs to try to reduce financial and emotional costs for Latinas.

from Health and Science https://ift.tt/Mwe3Ng8
https://ift.tt/81UPu96
https://ift.tt/sUMzlT8

New RSV protections for infants hit cost, insurance hurdles in U.S. rollout

Pfizer's maternal vaccine, Abrysvo, and Sanofi's monoclonal antibody, Beyfortus, were approved for expectant mothers and infants in the U.S. earlier this year.

from Health and Science https://ift.tt/ej3kHtf
https://ift.tt/81UPu96
https://ift.tt/sUMzlT8

Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic

Novo Nordisk's forecast only confirms the frenzy for Wegovy and Ozempic, which patients seek for their ability to help them lose significant weight over time.

from Health and Science https://ift.tt/pbem1ch
https://ift.tt/xaImUjt
https://ift.tt/RqEbSX4

UnitedHealth is back and lifting other health-care stocks with it, Jim Cramer says

UnitedHealth's (UNH) quality quarterly results Friday are good sign for the broader health-care landscape, CNBC's Jim Cramer said.

from Health and Science https://ift.tt/QAsH2ec
https://ift.tt/xaImUjt
https://ift.tt/RqEbSX4

Thursday, 12 October 2023

Here are 3 stocks in our portfolio that Goldman Sachs think will rally on earnings

It's encouraging to see our stocks on the bullish side of Goldman Sachs' new list of 25 tactical trades for earnings season.

from Health and Science https://ift.tt/jWLBIJO
https://ift.tt/xaImUjt
https://ift.tt/RqEbSX4

Incoming Walgreens CEO doesn't mention walkouts as he praises pharmacy staff

Growing labor pressure from pharmacy staff is just one of several challenges Tim Wentworth will have on his plate when he starts leading Walgreens.

from Health and Science https://ift.tt/pQ4D96n
https://ift.tt/xaImUjt
https://ift.tt/RqEbSX4

Walgreens profit outlook comes up short as demand declines for Covid vaccines and tests

Walgreens has now underperformed Wall Street's adjusted earnings expectations for two straight quarters. 

from Health and Science https://ift.tt/UgN4vDK
https://ift.tt/sDE4thj
https://ift.tt/dAPNzwq

Monthly Meeting Q&A with Jim Cramer on everything from tech to health care to industrials

Jim Cramer and Club portfolio director Jeff Marks answered member questions.

from Health and Science https://ift.tt/rHQhTyE
https://ift.tt/sDE4thj
https://ift.tt/dAPNzwq

Wednesday, 11 October 2023

Here's a rapid-fire update on all 36 stocks in our portfolio, including our latest addition

Jim Cramer ran through the names during the Club's October Monthly Meeting on Wednesday.

from Health and Science https://ift.tt/4pP6xsy
https://ift.tt/sDE4thj
https://ift.tt/dAPNzwq

Jim Cramer praises Walgreens new CEO pick, says buy the stock 'perhaps aggressively'

Tim Wentworth is the right choice to lead Walgreens (WBA) in its transition to offering more health-care services, CNBC's Jim Cramer said Wednesday.

from Health and Science https://ift.tt/0H6kDau
https://ift.tt/sDE4thj
https://ift.tt/dAPNzwq

Period care brands August, Rael and others form coalition to fight the 'tampon tax,' reimburse consumers

The initiative is the result of a new coalition of period care brands August, Cora, LOLA, The Honey Pot, Rael, Here We Flo, Saalt and DIVA.

from Health and Science https://ift.tt/VrybsBF
https://ift.tt/sDE4thj
https://ift.tt/dAPNzwq

Tuesday, 10 October 2023

Walgreens names veteran health-care executive Tim Wentworth as next CEO

Wentworth is the former CEO of the nation's largest pharmacy benefits management company, Express Scripts, which was acquired by Cigna in 2018.

from Health and Science https://ift.tt/uGf2R50
https://ift.tt/1ZqeyXx
https://ift.tt/pZxYza4

15 stocks with a history of dividend growth are expected to deliver once again this year

Broadcom (AVGO) and Eli Lilly (LLY) are among the 15 Club stocks with a streak of annual dividend growth that Wall Street expects to continue.

from Health and Science https://ift.tt/17ub3VS
https://ift.tt/1ZqeyXx
https://ift.tt/pZxYza4

Microsoft announces new AI tools to help doctors deliver better care

Microsoft introduced new solutions in Microsoft Fabric and Azure AI at the HLTH conference.

from Health and Science https://ift.tt/bhzU7Lm
https://ift.tt/1ZqeyXx
https://ift.tt/pZxYza4

How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company

How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company

from Health and Science https://ift.tt/hbaLxri
https://ift.tt/1ZqeyXx
https://ift.tt/pZxYza4

Supreme Court declines to hear case challenging FDA authority to reject flavored e-cigarettes

Avail Vapor's case is one of several challenges to the FDA's regulation of the vaping industry, which has hooked a new generation on nicotine in the U.S.

from Health and Science https://ift.tt/2eXtqTx
https://ift.tt/1ZqeyXx
https://ift.tt/pZxYza4

Monday, 9 October 2023

Cramer says Vertex has a drug that may address the 'largest market opportunity in the world'

CNBC's Jim Cramer said investors keep an eye on Vertex Pharmaceuticals (VRTX) as the company develops a non-opioid pain drug.

from Health and Science https://ift.tt/i3z2bXG
https://ift.tt/kboZXEs
https://ift.tt/8R7Xagn

Google announces new generative AI search capabilities for doctors

Google Cloud unveiled new AI search capabilities that will help clinicians quickly access information across different data sources. 

from Health and Science https://ift.tt/m3ytE78
https://ift.tt/kboZXEs
https://ift.tt/8R7Xagn

Saturday, 7 October 2023

Novavax's updated Covid vaccine can still catch up to Pfizer, Moderna shots this fall

Novavax's Covid shot is arriving nearly three weeks after new jabs from Pfizer and Moderna reached Americans — but analysts aren't worried about that delay. 

from Health and Science https://ift.tt/ycYrz0l
https://ift.tt/msPlOUE
https://ift.tt/qJjrpYG

Friday, 6 October 2023

Kaiser Permanente health workers threaten more strikes if demands not met

More than 75,000 workers are currently on strike in California, Colorado, Washington and Oregon.

from Health and Science https://ift.tt/QDcjMgu
https://ift.tt/R6GC3s1
https://ift.tt/g5Esoti

Here are all the portfolio moves the Club made in this week's oversold market

With the stock market deeply oversold, the Club put cash to work by picking stocks across a range of sectors including energy, technology and materials.

from Health and Science https://ift.tt/eJCWvag
https://ift.tt/R6GC3s1
https://ift.tt/g5Esoti

We're booking some profits on this health insurance stock after waiting out its slump

It's taken some patience. But shares of this company finally broke through $500 each in Friday trading, so we're ringing the register.

from Health and Science https://ift.tt/gxiLGyZ
https://ift.tt/R6GC3s1
https://ift.tt/g5Esoti

'Long colds' could be as common as 'long Covid' — with lasting effects, study says

A U.K. study showed that symptoms of a cold can linger well beyond the main period of illness, suggesting that like long Covid, "long colds" also exist.

from Health and Science https://ift.tt/3nqwLig
https://ift.tt/R6GC3s1
https://ift.tt/g5Esoti

Philips shares fall 8% after U.S. drug regulator deals fresh blow to sleep device recall

Shares of Dutch health tech company Philips fell on Friday after the U.S. drug regulator deemed its handling of a major product recall inadequate.

from Health and Science https://ift.tt/29pnQby
https://ift.tt/R6GC3s1
https://ift.tt/g5Esoti

Thursday, 5 October 2023

Do menopause retreats work — and why are people paying $15,000 for them?

The menopause market will be worth $600 billion by 2025, with more than one billion women reaching perimenopause between now and then.

from Health and Science https://ift.tt/sk736CY
https://ift.tt/R6GC3s1
https://ift.tt/g5Esoti

Kaiser Permanente workers strike for second day after negotiations fail to reach labor contract

The union coalition has described the work stoppage at Kaiser as the largest health-care worker strike in U.S. history.

from Health and Science https://ift.tt/GHFWoBd
https://ift.tt/nmNHvzt
https://ift.tt/DfdIW1m

Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says

The study comes as Novo Nordisk's Wegovy, Ozempic and similar treatments skyrocket in popularity in the U.S. for causing dramatic weight loss over time.

from Health and Science https://ift.tt/9VHCbkz
https://ift.tt/nmNHvzt
https://ift.tt/DfdIW1m

Neuralink competitor Precision Neuroscience buys factory to build its brain implants

Precision Neuroscience acquired a manufacturing facility that can produce the key component of its brain implant.

from Health and Science https://ift.tt/AMJ6Y0e
https://ift.tt/nmNHvzt
https://ift.tt/DfdIW1m

Wednesday, 4 October 2023

Lab owner who defrauded Medicare to forfeit $187 million, Ferrari

Lab owner Minal Patel filed nearly $500 million in false claims to Medicare for genetic tests.

from Health and Science https://ift.tt/3ZXUoxl
https://ift.tt/nmNHvzt
https://ift.tt/DfdIW1m

More than 75,000 workers to strike at hundreds of Kaiser Permanente health facilities across U.S.

The Coalition of Kaiser Permanente Unions has described the work stoppage as the largest strike of health-care workers in U.S. history.

from Health and Science https://ift.tt/zKa9WAw
https://ift.tt/RbYwjrJ
https://ift.tt/KHa3k9V

Moderna combination Covid, flu vaccine moves to final stage trial after positive data

Moderna and other vaccine makers like Pfizer believe combination shots will simplify what people can do to protect themselves against Covid, RSV and the flu.

from Health and Science https://ift.tt/NkBG1ub
https://ift.tt/RbYwjrJ
https://ift.tt/KHa3k9V

It's time to get bullish on this health tech name, now that it's shed a drag on growth

Going forward, we expect the underlying fundamentals at a more nimble Danaher to improve.

from Health and Science https://ift.tt/sQnixAI
https://ift.tt/RbYwjrJ
https://ift.tt/KHa3k9V

Novartis unit Sandoz set to start trading after completing spinoff

Novartis has completed the planned spin-off of its generics and biosimilars business, Sandoz, which will begin trading on the SIX Swiss Exchange on Wednesday.

from Health and Science https://ift.tt/XJNOkjy
https://ift.tt/RbYwjrJ
https://ift.tt/KHa3k9V

Tuesday, 3 October 2023

FDA authorizes updated Novavax Covid vaccine as Pfizer, Moderna shots roll out in U.S.

Health officials see Novavax's protein-based vaccine as a valuable alternative for people who don't want to take messenger RNA shots from Pfizer and Moderna.

from Health and Science https://ift.tt/IaAWd9F
https://ift.tt/RbYwjrJ
https://ift.tt/KHa3k9V

Monday, 2 October 2023

Drugmakers opt in to Medicare drug price negotiations – here's what happens next

The lengthy negotiation process with Medicare won't end until August 2024, with reduced prices going into effect in January 2026.

from Health and Science https://ift.tt/g6yCpi7
https://ift.tt/Ztz7XRM
https://ift.tt/MT64xXo

Kaiser Permanente union workers poised to strike after contract expires

The workers' contract with Kaiser Permanente expired Saturday with disagreements still simmering over staffing levels.

from Health and Science https://ift.tt/wBrQ87D
https://ift.tt/Ztz7XRM
https://ift.tt/MT64xXo

Sunday, 1 October 2023

Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom

Kellogg, J.M. Smucker and other food companies are making big bets on snacking, but the rise of Wegovy and Ozempic could pose a threat to future sales growth.

from Health and Science https://ift.tt/oUX4Syx
https://ift.tt/igqW0Dc
https://ift.tt/J7uABsc